CYLD and hepatocellular carcinoma: Five genes with de novo damaging alleles PIK3CA, TLN1 CYLD, and MAP2K1, are linked with cholangio- and hepatocellular carcinomas in addition to congenital syndromes and conditions related to tissue overgrowth [23–26].